Literature DB >> 7890386

Phospholipid composition of Pneumocystis carinii carinii and effects of methylprednisolone immunosuppression on rat lung lipids.

Z Guo1, E S Kaneshiro.   

Abstract

The phospholipid class composition of Pneumocystis carinii carinii freshly isolated from infected lungs generally resembled that of the host lung, suggesting that the parasite scavenges lung alveolar lipids. However, subtle quantitative differences were demonstrated, indicating that the pathogen has the metabolic capacity to de novo synthesize, or at least tailor, its lipids. The concentration of phosphatidylcholine, the major lung surfactant lipid, in the organism was lower than that in lungs of normal and immunosuppressed uninfected rats, and the concentration of phosphatidylinositol was higher. Phosphonolipids were not detected in the organism by chemical analysis and nuclear magnetic resonance spectrometry. The immunosuppressive regimen alone caused increases in both surfactant protein A and the lipid content of the whole lung. The lungs of rats that were subjected to corticosteroid immunosuppression and had heavy parasite loads had dramatically elevated surfactant protein A levels, whereas the lipid contents of these lungs were not different from lipid contents in whole lungs of immunosuppressed uninfected rats. P. carinii was found to concentrate lipids, indicating that a large amount of the lipids in the whole infected rat lung was within the parasites residing in the organ. These observations have important implications relevant to the use of corticosteroid therapy for P. carinii pneumonitis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890386      PMCID: PMC173148          DOI: 10.1128/iai.63.4.1286-1290.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  Variations among vertebrates of lung phospholipid case composition.

Authors:  C F Baxter; G Rouser; G Simon
Journal:  Lipids       Date:  1969-05       Impact factor: 1.880

Review 3.  Lung surfactant.

Authors:  J L Harwood
Journal:  Prog Lipid Res       Date:  1987       Impact factor: 16.195

4.  Characterizations of phospholipids from Paramecium tetraurelia cells and cilia.

Authors:  D E Rhoads; E S Kaneshiro
Journal:  J Protozool       Date:  1979-05

5.  Occurrence of specific sterols in Pneumocystis carinii.

Authors:  M Florin-Christensen; J Florin-Christensen; Y P Wu; L Zhou; A Gupta; H Rudney; E S Kaneshiro
Journal:  Biochem Biophys Res Commun       Date:  1994-01-14       Impact factor: 3.575

6.  Effect of sterol replacement in vivo on the fatty acid composition of Tetrahymena.

Authors:  K A Ferguson; F M Davis; R L Conner; J R Landrey; F B Mallory
Journal:  J Biol Chem       Date:  1975-09-10       Impact factor: 5.157

7.  Phospholipase activities of bronchoalveolar lavage fluid in rat Pneumocystis carinii pneumonia.

Authors:  S Kernbaum; J Masliah; L G Alcindor; C Bouton; D Christol
Journal:  Br J Exp Pathol       Date:  1983-02

8.  Phospholipid profile of Pneumocystis carinii and its interaction with alveolar type II epithelial cells.

Authors:  E L Pesanti
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

9.  Surfactant phospholipids and lavage phospholipase A2 in experimental Pneumocystis carinii pneumonia.

Authors:  P M Sheehan; D C Stokes; Y Y Yeh; W T Hughes
Journal:  Am Rev Respir Dis       Date:  1986-09

10.  Characterizations of six ethanolamine sphingophospholipids from Paramecium cells and cilia.

Authors:  E S Kaneshiro; D F Matesic; K Jayasimhulu
Journal:  J Lipid Res       Date:  1984-04       Impact factor: 5.922

View more
  6 in total

1.  Characterizations of neutral lipid fatty acids and cis-9,10-epoxy octadecanoic acid in Pneumocystis carinii carinii.

Authors:  E S Kaneshiro; J E Ellis; Z Guo; K Jayasimhulu; J N Maiorano; K A Kallam
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

2.  C27 to C32 sterols found in Pneumocystis, an opportunistic pathogen of immunocompromised mammals.

Authors:  E S Kaneshiro; M A Wyder
Journal:  Lipids       Date:  2000-03       Impact factor: 1.880

Review 3.  The lipids of Pneumocystis carinii.

Authors:  E S Kaneshiro
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

Review 4.  Sterol metabolism in the opportunistic pathogen Pneumocystis: advances and new insights.

Authors:  Edna S Kaneshiro
Journal:  Lipids       Date:  2004-08       Impact factor: 1.880

5.  Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study.

Authors:  N A Maskell; D J Waine; A Lindley; J C T Pepperell; A E Wakefield; R F Miller; R J O Davies
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

6.  Fatty acid composition of the major phospholipids of Pneumocystic carinii: comparison with those in the lungs of normal and methylprednisolone-immunosuppressed rats.

Authors:  Z Guo; D H Beach; E S Kaneshiro
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.